Stocks News

LAST PRICE
3.4900
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
3.4900/ 12
Ask / Lots
3.6000/ 5
Open / Previous Close
--- / 3.4900
Day Range
---
52 Week Range
Low 2.5000
High 19.6880
Volume
319
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Agenus Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: AGEN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AGEN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 29, 2024 04:52 ET (09:52 GMT)
Nov 27, 2024
- Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump, from 10:12AM ET on Wednesday Nov 27, 2024 by MT Newswires
  10:12AM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: AGEN
  10:12 AM EST, 11/27/2024 (MT Newswires) -- Agenus (AGEN) said Wednesday it has secured a $22 million mortgage backed by two California properties and is implementing an operational realignment plan to enhance its focus on botensilimab/balstilimab in...
- *DJ Agenus Secures $22M Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AGEN
- Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AGEN
  
  Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment
  LEXINGTON, Mass.--(BUSINESS WIRE)--November 27, 2024--
  Agenus Inc. ("Agenus" or the "Company") (Nasdaq: AGEN), an immuno-oncology company focused on innovation has successfully secured a $22 million non-amortizing mortgage backed by its Berkeley-based Biologics CMC facility ("901 Heinz") and its 66-acre biomanufacturing-zoned property in Vacaville, California. Facilitated by L&L Capital, the transaction yields $20 million in net proceeds after closing costs and interest reserve, bolstering the company's cash position ahead of anticipated additional cash infusions in the coming months. The mortgage, structured with a two-year term, carries interest payable in a 50% cash and 50% common stock arrangement, with rates set at 12% for Year 1 and 13% for Year 2.
Nov 18, 2024
- --B. Riley Adjusts Agenus Price Target to $11 From $18, Maintains Buy Rating, from 8:49AM ET on Monday Nov 18, 2024 by MT Newswires
  8:49AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: AGEN
  08:49 AM EST, 11/18/2024 (MT Newswires) -- Price: 4.1500, Change: +0.10, Percent Change: +2.47 ...

Nov 25, 2024
- Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by PR Newswire
  7:00AM ET on Monday Nov 25, 2024 by PR Newswire
  Companies Mentioned: KPTI
- Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones
  7:00AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: KPTI
Nov 22, 2024
- Seres Therapeutics to Participate in Piper Sandler Healthcare Conference, from 7:00AM ET on Friday Nov 22, 2024 by Dow Jones
  7:00AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: MCRB
Nov 20, 2024
- Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer, from 5:54PM ET on Wednesday Nov 20, 2024 by MT Newswires
  5:54PM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: KPTI
- Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by PR Newswire
  4:05PM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: KPTI
- Press Release: Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: KPTI
- Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: KPTI
Nov 18, 2024
- DJ Sutro Biopharma Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 7:32AM ET on Monday Nov 18, 2024 by Dow Jones
  7:32AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: STRO
- Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: KPTI
Nov 14, 2024
- DJ Seres Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:20AM ET on Thursday Nov 14, 2024 by Dow Jones
  11:20AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: MCRB

Agenus Inc
NASDAQ:AGENUnited States

Search Criteria

Today

DJ Agenus Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 2 hours ago by Dow Jones

Nov 27, 2024

Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump, from 10:12AM ET on Wednesday Nov 27, 2024 by MT Newswires

*DJ Agenus Secures $22M Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 18, 2024

--B. Riley Adjusts Agenus Price Target to $11 From $18, Maintains Buy Rating, from 8:49AM ET on Monday Nov 18, 2024 by MT Newswires

Peers Headlines

Nov 25, 2024

Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by PR Newswire

Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 22, 2024

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference, from 7:00AM ET on Friday Nov 22, 2024 by Dow Jones

Nov 20, 2024

Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer, from 5:54PM ET on Wednesday Nov 20, 2024 by MT Newswires

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by PR Newswire

Press Release: Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 18, 2024

DJ Sutro Biopharma Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 7:32AM ET on Monday Nov 18, 2024 by Dow Jones

Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 14, 2024

DJ Seres Therapeutics Is Maintained at Buy by Canaccord Genuity, from 11:20AM ET on Thursday Nov 14, 2024 by Dow Jones